BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2842252)

  • 1. Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies.
    Bartholomaeus WN; O'Donoghue H; Foti D; Lawson CM; Shellam GR; Reed WD
    Immunology; 1988 Jul; 64(3):397-405. PubMed ID: 2842252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to cardiac myosin in mouse cytomegalovirus myocarditis.
    O'Donoghue HL; Lawson CM; Reed WD
    Immunology; 1990 Sep; 71(1):20-8. PubMed ID: 2170269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis.
    Lawson CM; O'Donoghue HL; Reed WD
    Immunology; 1992 Mar; 75(3):513-9. PubMed ID: 1315309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine anti-cytomegalovirus monoclonal antibodies with autoreactivity.
    Lawson CM; O'Donoghue HL; Farrell HE; Shellam GR; Reed WD
    Immunology; 1991 Mar; 72(3):426-33. PubMed ID: 1851134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic control of mouse cytomegalovirus-induced myocarditis.
    Lawson CM; O'Donoghue H; Bartholomaeus WN; Reed WD
    Immunology; 1990 Jan; 69(1):20-6. PubMed ID: 2155871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of T cells in mouse cytomegalovirus myocarditis.
    Lawson CM; O'Donoghue H; Reed WD
    Immunology; 1989 May; 67(1):132-4. PubMed ID: 2544512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo model for the acute, latent and reactivated phases of cytomegalovirus infection.
    Gönczöl E; Danczig E; Boldogh I; Tóth T; Váczi L
    Acta Microbiol Hung; 1985; 32(1):39-47. PubMed ID: 2994350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine cytomegalovirus infection model in Balb/c mice--2. Pericarditis with myocardial involvement during virus infection.
    Leung WC; Hata J; Hashimoto K
    Tokai J Exp Clin Med; 1986 Oct; 11(4):303-11. PubMed ID: 3039696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral antibody response to individual viral proteins after murine cytomegalovirus infection.
    Selgrade MK; Huang YS; Graham JA; Huang CH; Hu PC
    J Immunol; 1983 Dec; 131(6):3032-5. PubMed ID: 6315823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of ocular murine cytomegalovirus infection.
    Hayashi K; Kurihara I; Uchida Y
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):486-93. PubMed ID: 2984137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with lipopolysaccharide and tumor necrosis factor.
    Lenzo JC; Fairweather D; Shellam GR; Lawson CM
    Cell Immunol; 2001 Oct; 213(1):52-61. PubMed ID: 11747356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoblot analysis of the antibody response to murine cytomegalovirus in genetically resistant and susceptible mice.
    Farrell HE; Shellam GR
    J Gen Virol; 1989 Oct; 70 ( Pt 10)():2573-86. PubMed ID: 2552004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of murine cytomegalovirus myocarditis: cellular infiltration of the heart and virus persistence.
    Lenzo JC; Fairweather D; Cull V; Shellam GR; James Lawson CM
    J Mol Cell Cardiol; 2002 Jun; 34(6):629-40. PubMed ID: 12054850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
    Lawson CM; Grundy JE; Shellam GR
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1987-98. PubMed ID: 2841411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell activation following murine cytomegalovirus infection: implications for autoimmunity.
    Price P; Olver SD; Gibbons AE; Shellam GR
    Immunology; 1993 Jan; 78(1):14-21. PubMed ID: 7679660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice.
    Yuhasz SA; Dissette VB; Cook ML; Stevens JG
    Virology; 1994 Jul; 202(1):272-80. PubMed ID: 8009839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine cytomegalovirus infection of cultured mouse embryos.
    Tsutsui Y; Naruse I
    Am J Pathol; 1987 May; 127(2):262-70. PubMed ID: 3034066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of temperature-sensitive mutants of mouse cytomegalovirus as vaccines.
    Sandford GR; Burns WH
    J Infect Dis; 1988 Sep; 158(3):596-601. PubMed ID: 2842407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance.
    Bancroft GJ; Shellam GR; Chalmer JE
    J Immunol; 1981 Mar; 126(3):988-94. PubMed ID: 6257788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retina and retinal pigment epithelial cell autoantibodies are produced during murine coronavirus retinopathy.
    Hooks JJ; Percopo C; Wang Y; Detrick B
    J Immunol; 1993 Sep; 151(6):3381-9. PubMed ID: 8397257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.